## PREMAL LULLA

| | Title| Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Or487WTnIoj4CIrp9Q%3d%3d&rnd=6fabf37d-93c2-4cf5-8f84-8efe8b6d5703)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=3010220)  
  

Other Positions| Title| Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Center for Cell & Gene Therapy  
Division| Center for Cell & Gene Therapy  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Miller A, Daum R, Wang T, Wu M, Tat C, Pfeiffer T, [Navai S](https://profiles.viictr.org/profile/6714386), [Heczey A](https://profiles.viictr.org/profile/268789), [Hegde M](https://profiles.viictr.org/profile/270076), [Ahmed N](https://profiles.viictr.org/profile/268944), [Whittle SB](https://profiles.viictr.org/profile/3009971), Hill L, [Martinez C](https://profiles.viictr.org/profile/265827), [Krance R](https://profiles.viictr.org/profile/268199), [Ramos CA](https://profiles.viictr.org/profile/267038), [Rouce RH](https://profiles.viictr.org/profile/3010108), **Lulla P** , [Heslop HE](https://profiles.viictr.org/profile/269811), [Omer B](https://profiles.viictr.org/profile/3009902), Shekar M. Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors. Cytotherapy. 2024 May 08. PMID: [38819365](//www.ncbi.nlm.nih.gov/pubmed/38819365).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

  2. Leung WK, Torres Chavez AG, French-Kim M, [Shafer P](https://profiles.viictr.org/profile/24845191), Mamonkin M, Hill LC, Kuvalekar M, Velazquez Y, Watanabe A, Watanabe N, Hoyos V, Lulla PD, [Leen AM](https://profiles.viictr.org/profile/268626), Leung WK, Torres Chavez AG, French-Kim M, Shafer P, [Mamonkin M](https://profiles.viictr.org/profile/1826306), Hill LC, Kuvalekar M, Velazquez Y, Watanabe A, [Watanabe N](https://profiles.viictr.org/profile/3009961), [Hoyos V](https://profiles.viictr.org/profile/23479202), **Lulla P** , Leen AM. Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024 Apr 25; 143(17):1726-1737. PMID: [38241630](//www.ncbi.nlm.nih.gov/pubmed/38241630); PMCID: [PMC11103096](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11103096).

Citations:  Fields:

Hem Hematology

  3. [Steffin D](https://profiles.viictr.org/profile/14348352), Ghatwai N, Montalbano A, Rathi P, [Courtney AN](https://profiles.viictr.org/profile/9596407), [Arnett AB](https://profiles.viictr.org/profile/34774547), Fleurence J, Sweidan R, Wang T, Zhang H, [Masand P](https://profiles.viictr.org/profile/269955), Maris JM, Martinez D, Pogoriler J, Varadarajan N, Thakkar SG, Lyon D, Lapteva N, [Mei Z](https://profiles.viictr.org/profile/267093), Patel K, [Lopez-Terrada D](https://profiles.viictr.org/profile/266283), [Ramos C](https://profiles.viictr.org/profile/267038), **Lulla P** , [Armaghany T](https://profiles.viictr.org/profile/28999477), [Grilley BJ](https://profiles.viictr.org/profile/266987), Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Sumazin P](https://profiles.viictr.org/profile/2560346), [Heczey A](https://profiles.viictr.org/profile/268789). Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers. Res Sq. 2024 Apr 03. PMID: [38645165](//www.ncbi.nlm.nih.gov/pubmed/38645165); PMCID: [PMC11030543](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11030543).

Citations:

  4. Hill LC, [Rouce RH](https://profiles.viictr.org/profile/3010108), Wu MJ, Wang T, Ma R, Zhang H, Mehta B, [Lapteva N](https://profiles.viictr.org/profile/269143), [Mei Z](https://profiles.viictr.org/profile/267093), Smith TS, Yang L, Srinivasan M, [Burkhardt PM](https://profiles.viictr.org/profile/31454204), [Ramos CA](https://profiles.viictr.org/profile/267038), **Lulla P** , Arredondo M, [Grilley B](https://profiles.viictr.org/profile/266987), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306). Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood. 2024 Mar 28; 143(13):1231-1241. PMID: [38145560](//www.ncbi.nlm.nih.gov/pubmed/38145560); PMCID: [PMC10997912](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10997912).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  5. Mathioudaki A, Wang X, Sedloev D, Huth R, Kamal A, Hundemer M, Liu Y, [Vasileiou S](https://profiles.viictr.org/profile/22016531), **Lulla P** , M?ller-Tidow C, Dreger P, Luft T, Sauer T, Schmitt M, Zaugg JB, Pabst C. The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature. Blood. 2024 Mar 28; 143(13):1269-1281. PMID: [38197505](//www.ncbi.nlm.nih.gov/pubmed/38197505); PMCID: [PMC10997908](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10997908).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38197505/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  6. Kapadia CD, Rosas G, Thakkar SG, Wu M, Torrano V, Wang T, [Grilley BJ](https://profiles.viictr.org/profile/266987), [Heslop HE](https://profiles.viictr.org/profile/269811), [Ramos CA](https://profiles.viictr.org/profile/267038), [Goodell MA](https://profiles.viictr.org/profile/269806), **Lulla PD**. Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy. Cytotherapy. 2024 03; 26(3):261-265. PMID: [38149948](//www.ncbi.nlm.nih.gov/pubmed/38149948); PMCID: [PMC10922117](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10922117).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

Translation:Humans

  7. [Badr H](https://profiles.viictr.org/profile/16943318), [Rouce R](https://profiles.viictr.org/profile/3010108), [Scheurer ME](https://profiles.viictr.org/profile/265805), **Lulla P** , Mims M, Reddy P. Bringing CAR T?cell therapy trials to underserved populations. Cancer Cell. 2023 12 11; 41(12):2007-2010. PMID: [37890490](//www.ncbi.nlm.nih.gov/pubmed/37890490); PMCID: [PMC11146682](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11146682).

Citations:  Fields:

Neo Neoplasms

Translation:Humans

  8. [Vasileiou S](https://profiles.viictr.org/profile/22016531), Hill L, Kuvalekar M, Workineh AG, Watanabe A, Velazquez Y, [Lulla S](https://profiles.viictr.org/profile/34811365), Mooney K, [Lapteva N](https://profiles.viictr.org/profile/269143), [Grilley BJ](https://profiles.viictr.org/profile/266987), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), Eagar TN, [Carrum G](https://profiles.viictr.org/profile/269657), Grimes KA, [Leen AM](https://profiles.viictr.org/profile/268626), **Lulla P**. Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients. Haematologica. 2023 Jul 01; 108(7):1840-1850. PMID: [36373249](//www.ncbi.nlm.nih.gov/pubmed/36373249); PMCID: [PMC10316279](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10316279).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36373249/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  9. [Quach DH](https://profiles.viictr.org/profile/3010661), **Lulla P** , [Rooney CM](https://profiles.viictr.org/profile/268355). Banking on virus-specific T cells to fulfill the need for?off-the-shelf cell therapies. Blood. 2023 02 23; 141(8):877-885. PMID: [36574622](//www.ncbi.nlm.nih.gov/pubmed/36574622); PMCID: [PMC10023738](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10023738).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  10. Pfeiffer T, Tzannou I, Wu M, [Ramos C](https://profiles.viictr.org/profile/267038), Sasa G, [Martinez C](https://profiles.viictr.org/profile/265827), **Lulla P** , [Krance RA](https://profiles.viictr.org/profile/268199), [Scherer L](https://profiles.viictr.org/profile/22016570), [Ruderfer D](https://profiles.viictr.org/profile/29852364), Naik S, [Bocchini C](https://profiles.viictr.org/profile/267713), Fraser IP, Patel B, Ward D, Wang T, [Heslop HE](https://profiles.viictr.org/profile/269811), [Leen AM](https://profiles.viictr.org/profile/268626), [Omer B](https://profiles.viictr.org/profile/3009902). Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting. Clin Cancer Res. 2023 01 17; 29(2):324-330. PMID: [36628536](//www.ncbi.nlm.nih.gov/pubmed/36628536); PMCID: [PMC9843433](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9843433).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36628536/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  11. **Lulla PD** , [Brenner M](https://profiles.viictr.org/profile/268200). Emerging Challenges to Cellular Therapy of Cancer. Cancer J. 2023 Jan-Feb 01; 29(1):20-27. PMID: [36693154](//www.ncbi.nlm.nih.gov/pubmed/36693154); PMCID: [PMC9881841](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9881841).

Citations:  Fields:

Neo Neoplasms

Translation:HumansCells

  12. Maneix L, Iakova P, Moree SE, Hsu JI, Mistry RM, Stossi F, **Lulla P** , Sun Z, [Sahin E](https://profiles.viictr.org/profile/267303), [Yellapragada SV](https://profiles.viictr.org/profile/267994), Catic A. Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 (HDAC3) Stabilization and Chromatin Condensation. Cancer Res Commun. 2022 12; 2(12):1693-1710. PMID: [36846090](//www.ncbi.nlm.nih.gov/pubmed/36846090); PMCID: [PMC9949381](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9949381).

Citations:  Translation:HumansCells

  13. Bajgain P, Torres Chavez AG, Balasubramanian K, Fleckenstein L, **Lulla P** , [Heslop HE](https://profiles.viictr.org/profile/269811), Vera J, [Leen AM](https://profiles.viictr.org/profile/268626). Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand-Expressing Solid Tumors. Cancer Immunol Res. 2022 11 02; 10(11):1370-1385. PMID: [36122411](//www.ncbi.nlm.nih.gov/pubmed/36122411); PMCID: [PMC9633434](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9633434).

Citations:

  14. [Hoyos V](https://profiles.viictr.org/profile/23479202), [Vasileiou S](https://profiles.viictr.org/profile/22016531), Kuvalekar M, Watanabe A, Tzannou I, Velazquez Y, French-Kim M, Leung W, [Lulla S](https://profiles.viictr.org/profile/34811365), Robertson C, Foreman C, Wang T, Bulsara S, [Lapteva N](https://profiles.viictr.org/profile/269143), [Grilley B](https://profiles.viictr.org/profile/266987), Ellis M, Osborne CK, Coscio A, [Nangia J](https://profiles.viictr.org/profile/266130), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), Vera JF, **Lulla P** , [Rimawi M](https://profiles.viictr.org/profile/269416), [Leen AM](https://profiles.viictr.org/profile/268626). Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer. Ther Adv Med Oncol. 2022; 14:17588359221107113. PMID: [35860837](//www.ncbi.nlm.nih.gov/pubmed/35860837); PMCID: [PMC9290161](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9290161).

Citations:

  15. [Steffin DHM](https://profiles.viictr.org/profile/14348352), Muhsen IN, Hill LC, [Ramos CA](https://profiles.viictr.org/profile/267038), [Ahmed N](https://profiles.viictr.org/profile/268944), [Hegde M](https://profiles.viictr.org/profile/270076), Wang T, Wu M, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Whittle SB](https://profiles.viictr.org/profile/3009971), **Lulla PD** , [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Omer B](https://profiles.viictr.org/profile/3009902), [Rouce RH](https://profiles.viictr.org/profile/3010108), [Heczey A](https://profiles.viictr.org/profile/268789), [Metelitsa LS](https://profiles.viictr.org/profile/266187), [Grilley BJ](https://profiles.viictr.org/profile/266987), Robertson C, Torrano V, [Lapteva N](https://profiles.viictr.org/profile/269143), [Gee AP](https://profiles.viictr.org/profile/268378), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811). Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24. PMID: [35325065](//www.ncbi.nlm.nih.gov/pubmed/35325065); PMCID: [PMC9346960](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9346960).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  16. Naik S, [Vasileiou S](https://profiles.viictr.org/profile/22016531), Tzannou I, Kuvalekar M, Watanabe A, Robertson C, [Lapteva N](https://profiles.viictr.org/profile/269143), Tao W, Wu M, [Grilley B](https://profiles.viictr.org/profile/266987), [Carrum G](https://profiles.viictr.org/profile/269657), [Kamble RT](https://profiles.viictr.org/profile/265557), Hill L, [Krance RA](https://profiles.viictr.org/profile/268199), [Martinez C](https://profiles.viictr.org/profile/265827), Tewari P, [Omer B](https://profiles.viictr.org/profile/3009902), [Gottschalk S](https://profiles.viictr.org/profile/270181), [Heslop HE](https://profiles.viictr.org/profile/269811), Brenner MK, [Rooney CM](https://profiles.viictr.org/profile/268355), Vera JF, [Leen AM](https://profiles.viictr.org/profile/268626), **Lulla PD**. Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant?in patients with ALL. Blood. 2022 04 28; 139(17):2706-2711. PMID: [35134127](//www.ncbi.nlm.nih.gov/pubmed/35134127); PMCID: [PMC9053698](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9053698).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/35134127/citedby/) Fields:

Hem Hematology

Translation:Humans

  17. **Lulla PD**. CAR T cells and autologous transplantation can coexist for DLBCL. Blood. 2022 03 03; 139(9):1266-1267. PMID: [35238887](//www.ncbi.nlm.nih.gov/pubmed/35238887); PMCID: [PMC8900274](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8900274).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  18. Friend BD, Muhsen IN, Patel S, Hill LC, **Lulla P** , [Ramos CA](https://profiles.viictr.org/profile/267038), Pingali SR, [Kamble RT](https://profiles.viictr.org/profile/265557), John TD, [Salem B](https://profiles.viictr.org/profile/29494168), [Bhar S](https://profiles.viictr.org/profile/3009970), [Doherty EE](https://profiles.viictr.org/profile/14348409), [Craddock J](https://profiles.viictr.org/profile/27841637), Sasa G, Wu M, Wang T, [Martinez C](https://profiles.viictr.org/profile/265827), [Krance RA](https://profiles.viictr.org/profile/268199), [Heslop HE](https://profiles.viictr.org/profile/269811), [Carrum G](https://profiles.viictr.org/profile/269657). Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplant. 2022 04; 57(4):579-585. PMID: [35105965](//www.ncbi.nlm.nih.gov/pubmed/35105965).

Citations:  Fields:

Tra Transplantation

Translation:Humans

  19. Hamadani M, Gopal AK, Pasquini M, Kim S, Qiu X, [Ahmed S](https://profiles.viictr.org/profile/12583951), Lazaryan A, Bhatt VR, Daly A, **Lulla P** , [Ciurea S](https://profiles.viictr.org/profile/12583873), Gauthier J, Agrawal V, Grover NS, Lekakis L, Modi D, Dahi PB, Herr MM, Johnson PC, Hashmi H, Hematti P, Locke FL. Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis. Blood Adv. 2022 01 25; 6(2):486-494. PMID: [34673903](//www.ncbi.nlm.nih.gov/pubmed/34673903); PMCID: [PMC8791562](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8791562).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34673903/citedby/) Fields:

Hem Hematology

Translation:Humans

  20. Hill LC, **Lulla PD**. COVID-specific T's may offset therapeutically endangered B's. Blood. 2022 01 06; 139(1):12-13. PMID: [34989773](//www.ncbi.nlm.nih.gov/pubmed/34989773); PMCID: [PMC8734939](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8734939).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34989773/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  21. Al Hadidi S, Dongarwar D, Salihu HM, [Kamble RT](https://profiles.viictr.org/profile/265557), **Lulla P** , Hill LC, [Carrum G](https://profiles.viictr.org/profile/269657), [Ramos CA](https://profiles.viictr.org/profile/267038), [Heslop HE](https://profiles.viictr.org/profile/269811), Usmani SZ. Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study. Leuk Lymphoma. 2021 12; 62(13):3256-3263. PMID: [34278937](//www.ncbi.nlm.nih.gov/pubmed/34278937); PMCID: [PMC8962656](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8962656).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34278937/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:Humans

  22. Streck BP, Naufal G, [Carrum G](https://profiles.viictr.org/profile/269657), Hill L, [Heslop HE](https://profiles.viictr.org/profile/269811), [Ramos CA](https://profiles.viictr.org/profile/267038), [Kamble R](https://profiles.viictr.org/profile/265557), Cohen M, East K, Sena M, **Lulla P**. Demographic and Clinical Donor Characteristics as Predictors of Total Nucleated Cell Concentrations in Harvested Marrow Products. Transplant Cell Ther. 2021 09; 27(9):785.e1-785.e6. PMID: [34082160](//www.ncbi.nlm.nih.gov/pubmed/34082160).

Citations:  Fields:

Hem HematologyTra Transplantation

Translation:HumansCells

  23. **Lulla PD** , Naik S, [Vasileiou S](https://profiles.viictr.org/profile/22016531), Tzannou I, Watanabe A, Kuvalekar M, [Lulla S](https://profiles.viictr.org/profile/34811365), [Carrum G](https://profiles.viictr.org/profile/269657), [Ramos CA](https://profiles.viictr.org/profile/267038), [Kamble R](https://profiles.viictr.org/profile/265557), Hill L, Randhawa J, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Krance R](https://profiles.viictr.org/profile/268199), Wang T, Wu M, Robertson C, [Gee AP](https://profiles.viictr.org/profile/268378), Chung B, [Grilley B](https://profiles.viictr.org/profile/266987), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Vera JF, [Leen AM](https://profiles.viictr.org/profile/268626). Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021 05 13; 137(19):2585-2597. PMID: [33270816](//www.ncbi.nlm.nih.gov/pubmed/33270816); PMCID: [PMC8120140](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8120140).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33270816/citedby/) Fields:

Hem Hematology

Translation:HumansCellsCTClinical Trials

  24. Linder K, **Lulla P**. Myelodysplastic syndrome and immunotherapy novel to next in-line treatments. Hum Vaccin Immunother. 2021 08 03; 17(8):2602-2616. PMID: [33941042](//www.ncbi.nlm.nih.gov/pubmed/33941042); PMCID: [PMC8475606](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8475606).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33941042/citedby/) Fields:

All Allergy and Immunology

Translation:Humans

  25. Maneix L, Sweeney MA, Lee S, Iakova P, Moree SE, [Sahin E](https://profiles.viictr.org/profile/267303), **Lulla P** , [Yellapragada SV](https://profiles.viictr.org/profile/267994), [Tsai FTF](https://profiles.viictr.org/profile/267524), [Catic A](https://profiles.viictr.org/profile/6541051). The Mitochondrial Protease LonP1 Promotes Proteasome Inhibitor Resistance in Multiple Myeloma. Cancers (Basel). 2021 Feb 17; 13(4). PMID: [33671345](//www.ncbi.nlm.nih.gov/pubmed/33671345); PMCID: [PMC7922145](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7922145).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33671345/citedby/)

  26. [Vasileiou S](https://profiles.viictr.org/profile/22016531), **Lulla PD** , Tzannou I, Watanabe A, Kuvalekar M, Callejas WL, Bilgi M, Wang T, Wu MJ, [Kamble R](https://profiles.viictr.org/profile/265557), [Ramos CA](https://profiles.viictr.org/profile/267038), [Rouce RH](https://profiles.viictr.org/profile/3010108), Zeng Z, [Gee AP](https://profiles.viictr.org/profile/268378), [Grilley BJ](https://profiles.viictr.org/profile/266987), Vera JF, Bollard CM, [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), [Rooney CM](https://profiles.viictr.org/profile/268355), [Leen AM](https://profiles.viictr.org/profile/268626), [Carrum G](https://profiles.viictr.org/profile/269657). T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects. J Clin Oncol. 2021 05 01; 39(13):1415-1425. PMID: [33507803](//www.ncbi.nlm.nih.gov/pubmed/33507803); PMCID: [PMC8274795](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8274795).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33507803/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  27. **Lulla PD** , Tzannou I, [Vasileiou S](https://profiles.viictr.org/profile/22016531), [Carrum G](https://profiles.viictr.org/profile/269657), [Ramos CA](https://profiles.viictr.org/profile/267038), [Kamble R](https://profiles.viictr.org/profile/265557), Wang T, Wu M, Bilgi M, [Gee AP](https://profiles.viictr.org/profile/268378), Mukhi S, Chung B, Wang L, Watanabe A, Kuvalekar M, [Jeong M](https://profiles.viictr.org/profile/3010235), Li Y, [Ketkar S](https://profiles.viictr.org/profile/28999445), French-Kim M, [Grilley B](https://profiles.viictr.org/profile/266987), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811), Vera JF, [Leen AM](https://profiles.viictr.org/profile/268626). The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma. Sci Transl Med. 2020 07 29; 12(554). PMID: [32727914](//www.ncbi.nlm.nih.gov/pubmed/32727914).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32727914/citedby/) Fields:

Med Medicine (General)Sci Science

Translation:Humans

  28. [Ramos CA](https://profiles.viictr.org/profile/267038), Grover NS, Beaven AW, **Lulla PD** , Wu MF, Ivanova A, Wang T, Shea TC, [Rooney CM](https://profiles.viictr.org/profile/268355), Dittus C, Park SI, [Gee AP](https://profiles.viictr.org/profile/268378), Eldridge PW, McKay KL, Mehta B, Cheng CJ, Buchanan FB, [Grilley BJ](https://profiles.viictr.org/profile/266987), Morrison K, [Brenner MK](https://profiles.viictr.org/profile/268200), Serody JS, Dotti G, [Heslop HE](https://profiles.viictr.org/profile/269811), Savoldo B. Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma. J Clin Oncol. 2020 11 10; 38(32):3794-3804. PMID: [32701411](//www.ncbi.nlm.nih.gov/pubmed/32701411); PMCID: [PMC7655020](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7655020).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32701411/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  29. Leung WK, Workineh A, Mukhi S, Tzannou I, Brenner D, [Watanabe N](https://profiles.viictr.org/profile/3009961), [Leen AM](https://profiles.viictr.org/profile/268626), **Lulla P**. Evaluation of cyclin A1-specific T cells as a potential treatment for acute myeloid leukemia. Blood Adv. 2020 Jan 28; 4(2):387-397. PMID: [31985805](//www.ncbi.nlm.nih.gov/pubmed/31985805); PMCID: [PMC6988407](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6988407).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31985805/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  30. Torres Chavez A, [McKenna MK](https://profiles.viictr.org/profile/23496083), Canestrari E, Dann CT, [Ramos CA](https://profiles.viictr.org/profile/267038), **Lulla P** , [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF, [Watanabe N](https://profiles.viictr.org/profile/3009961). Expanding CAR T cells in human platelet lysate renders T cells with in vivo longevity. J Immunother Cancer. 2019 11 28; 7(1):330. PMID: [31779709](//www.ncbi.nlm.nih.gov/pubmed/31779709); PMCID: [PMC6883585](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6883585).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31779709/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansAnimalsCells

  31. **Lulla PD** , [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Brenner MK](https://profiles.viictr.org/profile/268200). Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia. Cancer J. 2019 May/Jun; 25(3):199-207. PMID: [31135527](//www.ncbi.nlm.nih.gov/pubmed/31135527); PMCID: [PMC6602906](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6602906).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31135527/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  32. [Vasileiou S](https://profiles.viictr.org/profile/22016531), Turney AM, Kuvalekar M, Mukhi SS, Watanabe A, **Lulla P** , [Ramos CA](https://profiles.viictr.org/profile/267038), Naik S, Vera JF, Tzannou I, [Leen AM](https://profiles.viictr.org/profile/268626). Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infections. Haematologica. 2020 01; 105(1):235-243. PMID: [31004020](//www.ncbi.nlm.nih.gov/pubmed/31004020); PMCID: [PMC6939529](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6939529).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31004020/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  33. Hill L, **Lulla P** , [Heslop HE](https://profiles.viictr.org/profile/269811). CAR-T cell Therapy for Non-Hodgkin Lymphomas: A New Treatment Paradigm. Adv Cell Gene Ther. 2019 Jul; 2(3). PMID: [31777773](//www.ncbi.nlm.nih.gov/pubmed/31777773); PMCID: [PMC6880960](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6880960).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31777773/citedby/)

  34. Atilla E, Atilla PA, Mo F, Tashiro H, Srinivasan M, **Lulla P** , [Rouce RH](https://profiles.viictr.org/profile/3010108), [Ramos CA](https://profiles.viictr.org/profile/267038), [Brenner MK](https://profiles.viictr.org/profile/268200), [Mamonkin M](https://profiles.viictr.org/profile/1826306), Gomes-Silva D, Cabral JMS. CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia. Mol Ther. 2019 01 02; 27(1):272-280. PMID: [30391141](//www.ncbi.nlm.nih.gov/pubmed/30391141); PMCID: [PMC6318703](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6318703).

Citations:
[41](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30391141/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  35. Bajgain P, Tawinwung S, D'Elia L, Sukumaran S, [Watanabe N](https://profiles.viictr.org/profile/3009961), [Hoyos V](https://profiles.viictr.org/profile/23479202), **Lulla P** , [Brenner MK](https://profiles.viictr.org/profile/268200), [Leen AM](https://profiles.viictr.org/profile/268626), Vera JF. CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation. J Immunother Cancer. 2018 05 10; 6(1):34. PMID: [29747685](//www.ncbi.nlm.nih.gov/pubmed/29747685); PMCID: [PMC5944113](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5944113).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29747685/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:Humans

  36. **Lulla PD** , Hill LC, [Ramos CA](https://profiles.viictr.org/profile/267038), [Heslop HE](https://profiles.viictr.org/profile/269811). The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma. Clin Adv Hematol Oncol. 2018 May; 16(5):375-386. PMID: [29851933](//www.ncbi.nlm.nih.gov/pubmed/29851933); PMCID: [PMC6469642](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6469642).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29851933/citedby/) Fields:

Hem HematologyNeo Neoplasms

Translation:HumansCells

  37. Tzannou I, [Nicholas SK](https://profiles.viictr.org/profile/270011), **Lulla P** , Aguayo-Hiraldo PI, Misra A, [Martinez CA](https://profiles.viictr.org/profile/265827), Machado AA, Orange JS, [Piedra PA](https://profiles.viictr.org/profile/268114), Vera JF, [Leen AM](https://profiles.viictr.org/profile/268626). Immunologic Profiling of Human Metapneumovirus for the Development of Targeted Immunotherapy. J Infect Dis. 2017 09 15; 216(6):678-687. PMID: [28934427](//www.ncbi.nlm.nih.gov/pubmed/28934427); PMCID: [PMC5853664](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5853664).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28934427/citedby/) Fields:

Com Communicable Diseases

Translation:HumansCells

  38. Tzannou I, Papadopoulou A, Naik S, Leung K, [Martinez CA](https://profiles.viictr.org/profile/265827), [Ramos CA](https://profiles.viictr.org/profile/267038), [Carrum G](https://profiles.viictr.org/profile/269657), Sasa G, **Lulla P** , Watanabe A, Kuvalekar M, [Gee AP](https://profiles.viictr.org/profile/268378), Wu MF, Liu H, [Grilley BJ](https://profiles.viictr.org/profile/266987), [Krance RA](https://profiles.viictr.org/profile/268199), [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200), [Rooney CM](https://profiles.viictr.org/profile/268355), [Heslop HE](https://profiles.viictr.org/profile/269811), [Leen AM](https://profiles.viictr.org/profile/268626), [Omer B](https://profiles.viictr.org/profile/3009902). Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation. J Clin Oncol. 2017 Nov 01; 35(31):3547-3557. PMID: [28783452](//www.ncbi.nlm.nih.gov/pubmed/28783452); PMCID: [PMC5662844](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5662844).

Citations:
[135](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28783452/citedby/)
Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  39. Aguayo-Hiraldo PI, Arasaratnam RJ, Tzannou I, Kuvalekar M, **Lulla P** , Naik S, [Martinez CA](https://profiles.viictr.org/profile/265827), [Piedra PA](https://profiles.viictr.org/profile/268114), Vera JF, [Leen AM](https://profiles.viictr.org/profile/268626). Characterizing the Cellular Immune Response to Parainfluenza Virus 3. J Infect Dis. 2017 07 15; 216(2):153-161. PMID: [28472480](//www.ncbi.nlm.nih.gov/pubmed/28472480); PMCID: [PMC5853958](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5853958).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28472480/citedby/) Fields:

Com Communicable Diseases

Translation:HumansCells

  40. Tashiro H, Sauer T, Shum T, Parikh K, [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Omer B](https://profiles.viictr.org/profile/3009902), [Rouce RH](https://profiles.viictr.org/profile/3010108), **Lulla P** , [Rooney CM](https://profiles.viictr.org/profile/268355), [Gottschalk S](https://profiles.viictr.org/profile/270181), [Brenner MK](https://profiles.viictr.org/profile/268200). Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1. Mol Ther. 2017 09 06; 25(9):2202-2213. PMID: [28676343](//www.ncbi.nlm.nih.gov/pubmed/28676343); PMCID: [PMC5589064](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5589064).

Citations:
[61](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28676343/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  41. **Lulla P** , [Heslop HE](https://profiles.viictr.org/profile/269811). Fall of the mutants: T cells targeting BCR-ABL. Blood. 2017 02 02; 129(5):539-540. PMID: [28153834](//www.ncbi.nlm.nih.gov/pubmed/28153834); PMCID: [PMC5290991](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5290991).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28153834/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  42. **Lulla P** , [Ramos CA](https://profiles.viictr.org/profile/267038). Expanding Accessibility to CD19-CAR T Cells: Commercializing a "Boutique" Therapy. Mol Ther. 2017 01 04; 25(1):8-9. PMID: [28129132](//www.ncbi.nlm.nih.gov/pubmed/28129132); PMCID: [PMC5363183](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5363183).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28129132/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  43. **Lulla P** , [Heslop HE](https://profiles.viictr.org/profile/269811). Checkpoint inhibition and cellular immunotherapy in lymphoma. Hematology Am Soc Hematol Educ Program. 2016 Dec 02; 2016(1):390-396. PMID: [27913506](//www.ncbi.nlm.nih.gov/pubmed/27913506); PMCID: [PMC6142511](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6142511).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27913506/citedby/) Fields:

Hem Hematology

Translation:HumansCells

  44. Brammer JE, **Lulla P** , [Lynch GR](https://profiles.viictr.org/profile/269644). Retrospective review of extra-pulmonary small cell carcinoma and prognostic factors. Int J Clin Oncol. 2014 Oct; 19(5):822-8. PMID: [24122253](//www.ncbi.nlm.nih.gov/pubmed/24122253).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24122253/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  45. Kowalkowski MA, Mims MP, Amiran ES, **Lulla P** , Chiao EY. Effect of immune reconstitution on the incidence of HIV-related Hodgkin lymphoma. PLoS One. 2013; 8(10):e77409. PMID: [24098586](//www.ncbi.nlm.nih.gov/pubmed/24098586); PMCID: [PMC3788758](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3788758).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24098586/citedby/) Fields:

Med Medicine (General)Sci Science

Translation:HumansCells

  46. **Lulla PD** , Brammer JE, Bandeali S, [Lynch GR](https://profiles.viictr.org/profile/269644). Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib. J Gastrointest Cancer. 2013 Mar; 44(1):98-101. PMID: [23054578](//www.ncbi.nlm.nih.gov/pubmed/23054578).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23054578/citedby/) Fields:

Gas GastroenterologyNeo Neoplasms

Translation:Humans

  47. **Lulla P** , Bandeali S, Baker K. Fatal paraneoplastic systemic leukocytoclastic vasculitis as a presenting feature of chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk. 2011 Jun; 11 Suppl 1:S14-6. PMID: [22035741](//www.ncbi.nlm.nih.gov/pubmed/22035741).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22035741/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  48. Brammer JE, **Lulla P** , [Lynch GR](https://profiles.viictr.org/profile/269644). Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate. Int J Clin Oncol. 2011 Dec; 16(6):722-5. PMID: [21347630](//www.ncbi.nlm.nih.gov/pubmed/21347630).

Citations:
[8](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21347630/citedby/) Fields:

Neo Neoplasms

Translation:Humans

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 48 publications over 11 distinct years, with a maximum of
9 publications in
2022](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|9&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,22,0,33,0,0,11,67,33,44,33,67,100,67,56&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2011| 2  
2013| 3  
2016| 1  
2017| 6  
2018| 3  
2019| 4  
2020| 3  
2021| 6  
2022| 9  
2023| 6  
2024| 5  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

LULLA's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (187)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [T-Lymphocytes](https://profiles.viictr.org/profile/263702)
  * [Immunotherapy, Adoptive](https://profiles.viictr.org/profile/250092)
  * [Hematopoietic Stem Cell Transplantation](https://profiles.viictr.org/profile/244961)
  * [Lymphocyte Transfusion](https://profiles.viictr.org/profile/265021)
  * [Antigens, CD19](https://profiles.viictr.org/profile/260143)

[Explore](https://profiles.viictr.org/profile/3010220/198)

_

Co-Authors (61)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [LEEN, ANN](https://profiles.viictr.org/profile/268626)
  * [BRENNER, MALCOLM](https://profiles.viictr.org/profile/268200)
  * [RAMOS, CARLOS](https://profiles.viictr.org/profile/267038)
  * [VASILEIOU, SPYRIDOULA](https://profiles.viictr.org/profile/22016531)

[Explore](https://profiles.viictr.org/profile/3010220/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [CHAMPLIN, RICHARD E](https://profiles.viictr.org/profile/12582508)
  * [HESLOP, HELEN](https://profiles.viictr.org/profile/269811)
  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [GARCIA-MANERO, GUILLERMO](https://profiles.viictr.org/profile/12583738)

[Explore](https://profiles.viictr.org/profile/3010220/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [DERE, RUHEE](https://profiles.viictr.org/profile/18892307)
  * [DIAMOND, AKIVA](https://profiles.viictr.org/profile/31721883)
  * [ECKHARDT, GAIL](https://profiles.viictr.org/profile/41109789)
  * [HILSENBECK, SUSAN](https://profiles.viictr.org/profile/268374)
  * [MIMS, MARTHA](https://profiles.viictr.org/profile/266846)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [LIU, HAO](https://profiles.viictr.org/profile/265543)
  * [MEI, ZHUYONG](https://profiles.viictr.org/profile/267093)
  * [SULLIVAN, CATHY](https://profiles.viictr.org/profile/269017)
  * [UDDEN, MARK](https://profiles.viictr.org/profile/266554)
  * [YEN, AIHUA](https://profiles.viictr.org/profile/270002)

_

